Lumida
/ANIK
⌘K
Anika Therapeutics Inc

Anika Therapeutics Inc

ANIK
$21.34USD-2.02%-0.44 today

MARKET CAP

285.6M

P/E (TTM)

FWD P/E

DAY RANGE

$21 – $23

52W RANGE

$8
$23

AI Summary

Stalk
Sell NowMedium

ANIK is in a Stage 3 distribution phase, granting bearish medium-term permission. Short-term price is rejecting around the 9/21 EMAs and 50-day SMA, reflecting diminishing demand and structure failure. The preferred execution is selling into rallies near these resistance zones, aligning with the dominant downtrend while respecting potential short-term oversold bounces.

  • Q2 revenue rose 16% YoY to $32.6M, led by 17% commercial growth
  • Gross margin reached 65%, highest since 2020, driving profitability
  • OEM channel revenue down 17% YoY, highlighting pricing pressure from partners
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income